Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004010 · ClinicalTrials.gov registry record · Phase 2
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
A Phase 2 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 99
- Enrollment target
NCT00004010 is a Phase 2 study that has completed, run by Children's Oncology Group. The registered enrollment target is 99 participants.
The verdict
NCT00004010, a Phase 2 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 99 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. Radiation therapy uses high-energy x-rays to damage cancer cells. Giving radiation therapy after chemotherapy may be an effective treatment for Hodgkin's disease. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and radiation therapy in treating children who have previously untreated stage II, stage III, or stage IV Hodgkin's disease.
Interventions
- DRUG cyclophosphamide
- DRUG dacarbazine
- BIOLOGICAL filgrastim
- BIOLOGICAL bleomycin sulfate
- DRUG ABVD regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 1999-10 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004010
The ClinicalTrials.gov registry entry for NCT00004010 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cyclophosphamide is the first listed.
NCT00004010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004010 about?
NCT00004010 is a clinical study titled "Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease". RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. Radiation therapy uses high-energy x-rays to damage cancer cells. Giving radiation therapy after chemotherapy may be an ef...
What is the current status of trial NCT00004010?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 99 participants. The study started on 1999-10. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00004010?
The interventions under investigation include: cyclophosphamide (DRUG), dacarbazine (DRUG), filgrastim (BIOLOGICAL), bleomycin sulfate (BIOLOGICAL), ABVD regimen (DRUG).
Who is sponsoring clinical trial NCT00004010?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.